Alveron Pharma
PrivateLast Round
Seed
Dec 6, 2024
Total Funding Raised
$17.08M
Momentum Score
25 /100
Company Overview
Alveron Pharma is a drug discovery company developing a unique coagulation platform technology with the world's first cyclodextrin-based anticoagulant reversal drug.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alveron Pharma Comps
Public and private peers based on sector, stage, and business model.
Alveron Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 6, 2024 | ||||
| Debt | Oct 7, 2021 | ||||
| Series A Extension | Oct 7, 2021 | ||||
| Series A | May 16, 2019 |
Key People
Founding team and executive leadership
Alveron Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Waterman Ventures | Seed, Series A, Series A Extension |
| Thuja Capital | Seed, Series A Extension, Series A |
| Oost NL | Seed, Series A, Series A Extension |
| Broadview Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors grew 104% MoM, reaching 1.2K.
Alveron Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alveron Pharma's valuation, stock price, and market status.
